Clinical Trials Browser

pertuzumab × Tumor-Agnostic × 90 days × Clear all

NCT04802759 2026-05-11

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

Phase 1/2 Recruiting

Neoplasm Metastasis